Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FOUND: 2 - You Need To See This

Fauci to step down in December - Roll Call

Fauci will step down after more than 50 years of government service where he helped respond to HIV/AIDS, Zika, Ebola and COVID-19.

Roll Call

Fauci says he'll retire by end of Biden's term

Fauci has been serving as NIAID director since 1984.

Axios

Metaphors matter: Why changing the name 'monkeypox' may help curb the discriminatory language used to discuss it

As we pass the one-month milestone of the current monkeypox outbreak, reports are emerging that the World Health Organization (WHO) intends to change the name of the monkeypox virus to avoid stigma and discrimination. While this is an important step, more than a name change may be needed.

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

Anthony Fauci on the Aids crisis, monkeypox, trans rights and his retirement

In an exclusive interview with Io Dodds, Dr Anthony Fauci looks back on his decades-long career in public health

The Independent UK

White House pandemic adviser Anthony Fauci tests positive for Covid

The White House Covid expert is experiencing mild symptoms and has not been in close contact with the president

The Independent UK

Exclusive: Anthony Fauci on the Aids crisis, monkeypox, trans rights and his retirement (OLD)

In an exclusive interview with Io Dodds, Dr Anthony Fauci looks back on his decades-long career in public health

The Independent UK

Monkeypox FAQ: How is it transmitted? Where did it come from? What are the symptoms? Does smallpox vaccine prevent it?

With cases reported in a number of countries, human monkeypox infection is generating global interest and concern as an emerging infectious disease threat even in the midst of a slowly relenting COVID-19 pandemic.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

The Daily Biotech Pulse: Ampio Falls On Knee Osteoarthritis Trial Update, AstraZeneca's COVID-19 Antibody Data, CureVac-GSK's Bivalent COVID-19 Vaccine Data

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga

Time for an Operation Warp Speed to Develop Pan-Coronavirus Vaccines

Meanwhile the FDA dawdles over second boosters as new COVID-19 wave approaches

Reason

Moderna Moves Forward With Second HIV Vaccine Trial

Moderna Inc (NASDAQ:MRNA) has dosed the first participant in a clinical trial of an experimental human immunodeficiency virus (HIV) trimer mRNA vaccine (mRNA-1574). The open-label, multicenter, randomized Phase 1 trial (HVTN 302) is designed to evaluate the safety and immunogenicity of experimental HIV trimer mRNA vaccines. The primary hypothesis is that the soluble…

Benzinga

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

National Institutes of Health

National Institute of Allergy and Infectious Diseases

19 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.